Skip to main content

Keynote webinar | Spotlight on cardio-oncology

Live event recorded: Tuesday 16th May, 2023

Cancer-related cardiovascular sequelae increase the risks of morbidity and mortality, and threaten the chances patients experiencing healthy cancer survivorship. New ESC guidelines, focused on the intersectionality of these specialties, underpin this webinar explaining how best to care for cancer patients at risk of cardiovascular complications.

You must have an account and be logged in to access the recording of this webinar. The on-demand version is not accredited.

No account yet? Register here for free

Log in to watch the webinar

About this webinar


What we should all know about ESC guidelines on cardio-oncology 
Dr. Teresa López Fernández 

Immune checkpoint inhibitor-associated myocarditis 
Prof. Lorenz Lehmann

Biomarkers in cardio-oncology 
Prof. Rudolf de Boer  

Panel discussion with all experts  


Prof. Rudolf de Boer 
Clinical Cardiologist and Professor of Translational Cardiology at the University Medical Center Groningen, The Netherlands

Prof. Lorenz Lehmann
Professor of Cardiology, Heidelberg University Hospital, Heidelberg, Germany

Dr. Teresa López Fernández
Consultant Cardiologist, University Hospital La Paz, Madrid, Spain

Learning objectives

After participating in this program, learners will be able to: 

  • Apply the new ESC cardio-oncology guidelines to treatment of cancer patients with cardiovascular risks 
  • Identify and appraise the risks of cardiological outcomes in patients receiving immune-checkpoint inhibitor therapy 
  • Identify and utilize biomarkers as part of long-term follow-up of cardiovascular risks in cancer patients

Faculty information and disclosures

Prof. Rudolf de Boer

Prof. de Boer is a Clinical Cardiologist, a Professor of Translational Cardiology, and the Director of the Experimental Cardiology at the University Medical Center Groningen, the Netherlands.


  • Grant/research support: AstraZeneca, Abbott, Boehringer Ingelheim, Cardio Pharmaceuticals GmbH, Ionis Pharmaceuticals Inc, Novo Nordisk, Roche
  • Speaker’s Bureau: Abbott, AstraZeneca, Bayer, Bristol Myers Squibb, Novartis, Roche

Prof. Lorenz Lehmann

Prof. Lorenz Lehmann is a Clinical Cardiologist, a Professor of Cardiology and the Head of the Institute of Cardio-Oncology as well as the Special Outpatient Clinic for Cardio-Oncology at the Heidelberg University Hospital. 


  • Honoraria/consultation fees: Daiichi Sankyo, Senaca, AstraZeneca, Servier
  • Speaker’s Bureau: Novartis, MSD

Dr. Teresa López Fernández

Dr. López Fernández leads the Cardio-Oncology Unit at University Hospital La Paz, Madrid, where she specializes in cardiac imaging. 


  • Honoraria/consultation fees: Philips, Myocardial Solutions
  • Speaker’s Bureau: Janssen, Daiichi Sankyo, AstraZeneca, Beigene


Dr. Jane Godsland

Clinical Director, Springer Medicine, Springer Healthcare, London, United Kingdom


  • No disclosure to declare

Dr. Erik Heintz

Editor-in-Chief, Springer Medizin Verlag GmbH, Munich, Germany 


  • No disclosure to declare

Stay tuned for more webinars from Springer Medicine

Receive email notifications about the broadcast dates of future webinars by subscribing to "Springer Medicine Updates"

No account yet? Click here to register for free